Blog

Cultural Relevance in Medical Adherence: Pre, During and Post Pandemic

In the US, medical non-adherence accounts for 30-50% percent of chronic disease treatment failures and close to 125,000 preventable deaths each year, representing losses of $637 billion for the pharmaceutical industry. The COVID-19 pandemic has created additional strain as healthcare utilization dropped significantly .  82% of healthcare providers surveyed indicated a significant decline in appointments […]

Driving Diversity in Clinical Trials

A recent article published by Clinical Leader illustrates the importance of making information about clinical trial participation accessible to those who are currently under-represented in pharmaceutical research. The findings concluded that understanding where minority groups are currently going to find further information is a good start to bridging the existing disparities in Clinical Research by […]

New European Union regulations for medical devices and in vitro devices — Are you ready to thrive in the new landscape?

On May 26th, 2020, the new Medical Devices Regulation (MDR) will be fully enforced and applied to the approximately 500,000 medical devices being sold in the EU. Soon after the MDR comes into full force, the In Vitro Devices Regulation (IVDR) will also replace the old directive, in May 2022. These new regulations put a […]